MAZZONI, MARIA ROSA
 Distribuzione geografica
Continente #
NA - Nord America 9.487
AS - Asia 4.287
EU - Europa 3.383
SA - Sud America 552
AF - Africa 182
OC - Oceania 9
Totale 17.900
Nazione #
US - Stati Uniti d'America 9.265
SG - Singapore 1.309
CN - Cina 1.260
IT - Italia 1.131
HK - Hong Kong 706
SE - Svezia 514
DE - Germania 466
BR - Brasile 454
VN - Vietnam 325
BG - Bulgaria 269
TR - Turchia 198
CA - Canada 195
FI - Finlandia 180
GB - Regno Unito 171
FR - Francia 157
KR - Corea 149
UA - Ucraina 149
RU - Federazione Russa 114
JP - Giappone 89
IN - India 64
CI - Costa d'Avorio 63
CH - Svizzera 61
AT - Austria 50
BD - Bangladesh 41
AR - Argentina 38
BE - Belgio 25
IQ - Iraq 22
ID - Indonesia 21
SN - Senegal 21
PK - Pakistan 20
ZA - Sudafrica 20
KE - Kenya 18
PL - Polonia 17
NL - Olanda 16
VE - Venezuela 16
ES - Italia 15
MA - Marocco 13
LT - Lituania 12
UZ - Uzbekistan 12
CO - Colombia 11
PH - Filippine 11
EC - Ecuador 10
MY - Malesia 9
DZ - Algeria 8
NG - Nigeria 8
PY - Paraguay 8
EG - Egitto 7
MX - Messico 7
PT - Portogallo 7
TN - Tunisia 7
UY - Uruguay 7
AU - Australia 6
ET - Etiopia 6
IE - Irlanda 6
SA - Arabia Saudita 6
OM - Oman 5
BO - Bolivia 4
CZ - Repubblica Ceca 4
GR - Grecia 4
JM - Giamaica 4
TH - Thailandia 4
TW - Taiwan 4
CL - Cile 3
GE - Georgia 3
IL - Israele 3
IR - Iran 3
KZ - Kazakistan 3
NZ - Nuova Zelanda 3
RO - Romania 3
AE - Emirati Arabi Uniti 2
AL - Albania 2
AM - Armenia 2
AZ - Azerbaigian 2
CR - Costa Rica 2
EE - Estonia 2
KG - Kirghizistan 2
LB - Libano 2
ML - Mali 2
NI - Nicaragua 2
PA - Panama 2
QA - Qatar 2
RS - Serbia 2
SY - Repubblica araba siriana 2
TT - Trinidad e Tobago 2
AO - Angola 1
BF - Burkina Faso 1
BJ - Benin 1
BN - Brunei Darussalam 1
BS - Bahamas 1
BY - Bielorussia 1
CG - Congo 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
GD - Grenada 1
GT - Guatemala 1
HN - Honduras 1
HR - Croazia 1
IS - Islanda 1
JO - Giordania 1
KW - Kuwait 1
Totale 17.886
Città #
Woodbridge 995
Ann Arbor 882
Ashburn 850
Dallas 773
Singapore 706
Hong Kong 698
Houston 651
Fairfield 566
Santa Clara 558
Chandler 555
San Jose 420
Serra 299
Sofia 269
Beijing 262
Milan 258
Shanghai 246
Wilmington 207
Cambridge 203
Seattle 201
New York 187
Jacksonville 180
Hefei 163
Ottawa 163
Seoul 145
Izmir 133
Boardman 127
Princeton 117
Lawrence 109
Los Angeles 109
Lauterbourg 100
Medford 100
Nanjing 88
Tokyo 84
Munich 76
Dearborn 65
Abidjan 63
Ho Chi Minh City 63
Des Moines 61
Florence 61
Hanoi 59
Council Bluffs 58
Bern 53
Dong Ket 51
Bergamo 50
London 48
Istanbul 47
Helsinki 44
São Paulo 44
Buffalo 43
The Dalles 43
Pisa 42
Frankfurt am Main 39
Columbus 38
Chicago 37
Vienna 37
Nanchang 34
Redondo Beach 33
Boulder 32
Jüchen 29
Nürnberg 28
San Diego 28
Fuzhou 27
Ogden 26
Turku 26
Brussels 23
Shenyang 22
Changsha 21
Dakar 21
Trieste 20
Rome 18
Düsseldorf 16
Hebei 16
Kunming 16
Rio de Janeiro 16
Bremen 15
Johannesburg 15
Marseille 15
Nairobi 15
Orem 15
Ribeirão Preto 15
Belo Horizonte 14
Pune 14
Warsaw 14
Hangzhou 13
Livorno 13
Norwalk 13
Quanzhou 13
Redwood City 13
Da Nang 12
Jakarta 12
Lancaster 12
Tashkent 12
Auburn Hills 11
Falls Church 11
Guangzhou 11
Phoenix 11
Baghdad 10
Brooklyn 10
Atlanta 9
Caracas 9
Totale 13.305
Nome #
A Novel Panel of Serum Biomarkers for MPM Diagnosis 303
Ultra-high resolution MALDI-FTICR-MSI analysis of intact proteins in mouse and human pancreas tissue 266
Comparative proteomic analysis of malignant pleural mesothelioma: Focusing on the biphasic subtype 258
[H-3] OUABAIN BINDING TO OX BRAIN MEMBRANES - CHARACTERIZATION OF A HIGH-AFFINITY BINDING-SITE 238
Altered Protease-Activated Receptor-1 Expression and Signaling in a Malignant Pleural Mesothelioma Cell Line, NCI-H28, with Homozygous Deletion of the beta-Catenin Gene. 238
null 236
Proteomic analysis of fine-needle aspiration in differential diagnosis of thyroid nodules. 229
Focus on Human Monoamine Transporter Selectivity. New Human DAT and NET Models, Experimental Validation, and SERT Affinity Exploration 229
Putative salivary biomarkers useful to differentiate patients with fibromyalgia 227
Serum mesothelin, osteopontin and vimentin: useful markers for clinical monitoring of malignant pleural mesothelioma 223
URIC-ACID METABOLISM IN 2 PATIENTS WITH COEXISTENT DOWNS-SYNDROME AND GOUT 222
Proteomic Investigation of Malignant Major Salivary Gland Tumors 221
Parathyroid Carcinoma and Adenoma Co-existing in One Patient: Case Report and Comparative Proteomic Analysis 221
Toward patient-tailored therapy in agonist opioid treatment: The role of psychopathology, craving behavioural covariates, stress reaction and methadone blood concentration. A case series 221
Proteomics insight into psychiatric disorders: an update on biological fluid biomarkers 208
Inhibition of [125] ET-1 binding to ETA receptors by salicilic acid dimers 207
3-[(aryl)(4-fluorobenzyloxy)methyl]piperidine derivatives: high-affinity ligands for the serotonin transporter 205
A MONOCLONAL-ANTIBODY TO THE ALPHA-SUBUNIT OF GK BLOCKS MUSCARINIC ACTIVATION OF ATRIAL K+ CHANNELS 204
ADENOSINE RECEPTORS IN RAT TESTIS 201
Role of Prosaposin and Extracellular Sulfatase Sulf-1 Detection in Pleural Effusions as Diagnostic Biomarkers of Malignant Mesothelioma 200
Driving forces in the delivery of penetratin conjugated G protein fragment 198
Putative biomarkers for malignant pleural mesothelioma suggested by proteomic analysis of cell line secretome 194
Regulation of platelet serotonin transporter by protein kinase C 193
Proteolytic Fragmentation for Epitope Mapping 193
Urate binding globulin, interactions with immunoglobulins. 190
Proteolytic fragmentation for epitope mapping 189
Integrative neuro-cardiovascular dynamics in response to test anxiety: A brain-heart axis study 187
Structure-activity analysis of C-terminal endothelin analogues 185
A Proteomic Approach to Uncover Neuroprotective Mechanisms of Oleocanthal against Oxidative Stress 185
Dysregulation of PAR1 expression and signaling in a mesothelioma cell line, NCI-H28, with homozygous deletion of the β-catenin gene. 183
Interaction of transducin with light-activated rhodopsin protects it from proteolytic digestion by trypsin 182
Palmitate-induced lipotoxicity alters acetylation of multiple proteins in clonal β cells and human pancreatic islets 180
Insights into G protein structure, function, and regulation 177
4-ARYLPIPERIDINE DERIVATIVES AND USE THEREOF FOR PREPARING A MEDICAMENT FOR THE TREATMENT OF CNS DISEASE 175
Botton-up proteomics suggests an association between differential expression of mitochondrial proteins and chronic fatigue syndrome 175
Pharmacological intervention at CCR1 and CCR5 as an approach for cancer: help or hindrance 173
Alkylation of sulfhydryl groups on G alpha(s/olf) subunits by N-ethylmaleimide: regulation by guanine nucleotides 172
Antioxidant and neuroprotective activity of extra virgin olive oil extracts obtained from quercetano cultivar trees grown in different areas of the tuscany region (Italy) 171
EFFECT OF MONOCLONAL-ANTIBODY BINDING ON ALPHA-BETA-GAMMA-SUBUNIT INTERACTIONS IN THE ROD OUTER SEGMENT G-PROTEIN, GT 170
URATE BINDING HUMAN SERUM PROTEINS 169
URATE BINDING ALPHA-2-GLOBULIN - SPECIFIC ANTIBODY PREPARATION 168
STRUCTURAL-ANALYSIS OF ROD GTP-BINDING PROTEIN, GT - LIMITED PROTEOLYTIC DIGESTION PATTERN OF GT WITH 4 PROTEASES DEFINES MONOCLONAL-ANTIBODY EPITOPE 167
CONTROLLED MULTI-CENTER TRIAL OF TIOPRONIN AND D-PENICILLAMINE FOR RHEUMATOID-ARTHRITIS 167
Limited proteolytic digestion studies of G protein-receptor interactions 160
Effects of postmortem delay on serotonin and (+)8-OH-DPAT-mediated inhibition of adenylyl cyclase activity in rat and human brain tissues 160
Brain mitochondrial proteome alteration driven by creatine deficiency suggests novel therapeutic venues for creatine deficiency syndromes 160
Gender and age-related variation in adenylyl cyclase activity in the human prefrontal cortex, hippocampus and dorsal raphe nuclei 159
Modulation of PAR(1) signaling by benzimidazole compounds 158
Endothelin-1 up-regulates p115RhoGEF in embryonic rat cardiomyocytes during the hypertrophic response 157
Lack of stereoselectivity of 8-hydroxy-2(di-N-propylamino)tetralin-mediated inhibition of forskolin-stimulated adenylyl cyclase activity in human pre- and post-synaptic brain regions 155
ERYTHRO AND THREO 2-HYDROXYNONYL SUBSTITUTED 2-PHENYLADENINES AND 2-PHENYL-8-AZAADENINES: LIGANDS FOR A1 ADENOSINE RECEPTORS AND ADENOSINE DEAMINASE 153
Thrombin modulates the expression of a set of genes including thrombospondin-1 in human microvascular endothelial cells 152
Synthesis and functional evaluation of Adenosine A2A receptor ligand 151
Regulation of the platelet serotonin transporter by protein kinase C in the young and elderly 151
Allosteric inhibition of ET-1 binding to ETA receptors by aldoxime derivatives 151
A cell-penetrating peptide combined with Gas C-terminalsequence as inhibitor of A2A adenosine receptor signaling in PC12 cells 150
Salivary psoriasin (S100A7) correlates with diffusion capacity of carbon monoxide in a large cohort of systemic sclerosis patients 148
Antagonists of the receptor-G protein interface block G(1)-coupled signal transduction 147
Probing the shape of a hydrophobic pocket in the active site of delta-opioid antagonists 147
Morphiceptin analogues containing a dipeptide mimetic structure: An investigation on the bioactive topology at the mu-receptor 147
Synthesis and structure-activity relationship studies of new endothelin pseudopeptide analogues containing alkyl spacers 147
Expression of ETa receptors, G alpha subunits and RGS protein during H9c2 cardiac cells differentiation 146
Salivary Proteome Changes in Response to Acute Psychological Stress Due to an Oral Exam Simulation in University Students: Effect of an Olfactory Stimulus 146
The Protective Action of Metformin against Pro-Inflammatory Cytokine-Induced Human Islet Cell Damage and the Mechanisms Involved 146
A membrane-permeable peptide containing the last 21 residues of the G alpha(S) carboxyl terminus inhibits G(S)-coupled receptor signaling in intact cells: Correlations between peptide structure and biological activity 144
2 '-C-methyl analogues of selective adenosine receptor agonists: Synthesis and binding studies 143
A cell-penetrating peptide combined with the G alpha(s) C-terminal sequence as inhibitor of A(2A) adenosine receptor signaling in PC12 cells 143
Polymorphism Pro64His within galectin-3 has functional consequences at proteome level in thyroid cells 142
Toward the rational development of peptidomimetic analogs of the C-terminal endothelin hexapeptide: development of a theoretical model 140
A G alpha(s) carboxyl-terminal peptide prevents G(s) activation by the A(2A) adenosine receptor 140
A MONOCLONAL-ANTIBODY AGAINST THE ROD OUTER SEGMENT GUANYL NUCLEOTIDE-BINDING PROTEIN, TRANSDUCIN, BLOCKS THE STIMULATORY AND INHIBITORY-G PROTEINS OF ADENYLATE-CYCLASE 140
Proteomic Profling Reveals Specifc Molecular Hallmarks of the Pig Claustrum 138
Characterization of a low affinity-binding site for N-6-substituted adenosine derivatives in rat testis membranes 138
Characterization of Adenosine Receptors in Mullus surmuletus 138
ETB-receptor subtypes in guinea-pig bronchi 136
Conformational changes at the carboxyl terminus of G alpha occur during G protein activation 136
Are "traditional" biochemical techniques out of fashion in the new era of GPCR pharmacology? 135
GUANINE NUCLEOSIDE DIPHOSPHATE AND TRIPHOSPHATE MODULATE [H-3] CGS 21680 BINDING TO A2 ADENOSINE RECEPTOR IN RAT STRIATAL MEMBRANES 135
Fluorescent probes as indicators of conformation changes in transducin on activation 134
URATE BINDING-PROTEINS IN PLASMA STUDIES BY AFFINITY CHROMATOGRAPHY 133
A structure-activity relationship study on position-2 of the G alpha(s) C-terminal peptide able to inhibit G(s) activation by A(2A) adenosine receptor 131
Structural and biological studies of a penetratin linked G alpha(s) C-terminal peptide 130
Regulation of agonist binding to A2A adenosine receptors: effects of guanine nucleotides (GDP[S] and GTP[S]) and Mg2+ ion. 128
Modulation of A(1) adenosine receptor signaling by peroxynitrite 127
4-(4-Phenylsubstituted)-1,2,3-triazolacetic acid derivatives in vitro inhibitors of prostaglandin synthesis 126
A structure-activity study of a C-terminal endothelin analogue 124
Characterization of an urate binding alpha 2-globulin from human serum. 124
Increased inhibitory activity of protein kinase C on the serotonin transporter in OCD 122
Allosteric inhibition of (125I) ET-1 binding to ET(A) receptors by aldoxime and hydroxamic acid derivatives 121
Synthesis and evaluation of beta3-adrenergic affinity of new oximethereal derivative 120
Oximethereal piperidinic derivatives: synthesis and affinity for serotonin and dopamine transporters 120
ISOLATION OF AN URATE-BINDING PROTEIN BY AFFINITY-CHROMATOGRAPHY 118
Modulation of endothelin-A receptor, G alpha subunit, and RGS2 expression during H9c2 cardiomyoblast differentiation 118
4-Benzoyl- and 4-benzyl-1,2,3-triazol-N-acetic acids, in vitro inhibitors of the prostaglandin synthesis 118
N-Benzyl-4-Phenyl-1,2,3-triazole derivatives as in vitro inhibitors of the prostaglandin synthesis 115
SYNTHESIS AND AFFINITY FOR SEROTONIN TRANSPORTER OF NEW PIPERIDINE BASED BIVALENT LIGANDS 114
Binding characteristics of ET receptors in retinal pericytes and effects of high glucose incubation 112
Identifying bias in CCR1 antagonists using radiolabelled binding, receptor internalization, β-arrestin translocation and chemotaxis assays. 108
Regulation of agonist binding to rat ETB receptors by cations and GTP gamma S 106
TRYPTOPHAN207 IS INVOLVED IN THE GTP-DEPENDENT CONFORMATIONAL SWITCH IN THE ALPHA-SUBUNIT OF THE G-PROTEIN TRANSDUCIN - CHYMOTRYPTIC DIGESTION PATTERNS OF THE GTP-GAMMA-S AND GDP-BOUND FORMS 105
Totale 16.493
Categoria #
all - tutte 48.508
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 48.508


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021190 0 0 0 0 0 0 0 0 0 0 46 144
2021/20221.212 27 64 19 64 200 163 85 72 55 36 68 359
2022/20231.607 199 238 104 163 166 198 16 119 280 5 104 15
2023/20241.158 155 127 176 67 172 192 46 22 18 16 44 123
2024/20253.654 19 132 37 239 408 379 294 214 360 453 447 672
2025/20264.059 257 651 783 314 380 356 580 187 238 305 8 0
Totale 18.100